Testosterone transdermal - Warner Chilcott/Watson

Drug Profile

Testosterone transdermal - Warner Chilcott/Watson

Alternative Names: Intrinsa; Intrinsa CHF; Livensa; Testosterone transdermal TheraDerm MTX; WC3048; WC3049

Latest Information Update: 15 Jul 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Watson Laboratories
  • Developer Noven Pharmaceuticals; Procter & Gamble; Warner Chilcott; Watson Laboratories
  • Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Hormonal replacements; Small molecules; Testosterone congeners
  • Mechanism of Action Testosterone congener stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Market Withdrawal Female sexual dysfunction
  • Suspended Heart failure
  • No development reported Hypogonadism
  • Discontinued Cachexia; Menopausal syndrome; Postmenopausal osteoporosis

Most Recent Events

  • 23 Jan 2015 Biomarkers information updated
  • 01 Oct 2013 Warner Chilcott has been acquired and merged into Actavis Inc
  • 05 Jul 2013 No development reported - Phase-II for Hypogonadism in USA (Transdermal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top